NantHealth (NantHealth) Days Sales Outstanding

: 37.08 (As of Sep. 2023)

View and export this data going back to 2016. Start your Free Trial

NantHealth's average Accounts Receivable for the three months ended in Sep. 2023 was $5.07 Mil. NantHealth's Revenue for the three months ended in Sep. 2023 was $12.47 Mil. Hence, NantHealth's Days Sales Outstanding for the three months ended in Sep. 2023 was 37.08.

The historical rank and industry rank for NantHealth's Days Sales Outstanding or its related term are showing as below:

NHIQ' s Days Sales Outstanding Range Over the Past 10 Years
Min: 23.57 Med: 48.77 Max: 54.99
Current: 31.93

During the past 9 years, NantHealth's highest Days Sales Outstanding was 54.99. The lowest was 23.57. And the median was 48.77.

NHIQ's Days Sales Outstanding is ranked better than
67.66% of 637 companies
in the Healthcare Providers & Services industry
Industry Median: 46.01 vs NHIQ: 31.93

NantHealth's Days Sales Outstanding increased from Sep. 2022 (28.38) to Sep. 2023 (37.08).

NantHealth Days Sales Outstanding Historical Data

The historical data trend for NantHealth's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NantHealth Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Days Sales Outstanding

Get a 7-Day Free Trial

54.62

50.59

23.57

26.46

32.03

NantHealth Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Days Sales Outstanding	Get a 7-Day Free Trial															28.38	29.33	33.93	32.49	37.08

Competitive Comparison

For the Health Information Services subindustry, NantHealth's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

NantHealth Days Sales Outstanding Distribution

For the Healthcare Providers & Services industry and Healthcare sector, NantHealth's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where NantHealth's Days Sales Outstanding falls into.

NantHealth Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

NantHealth's Days Sales Outstanding for the fiscal year that ended in Dec. 2022 is calculated as

	Days Sales Outstanding (A: Dec. 2022 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2021 )	+	Accounts Receivable (A: Dec. 2022 ))	/	count )	/	Revenue (A: Dec. 2022 )	*	Days in Period
=	( (5.81	+	5.948)	/	2 )	/	67.002	*	365
=	5.879					/	67.002	*	365
=	32.03

NantHealth's Days Sales Outstanding for the quarter that ended in Sep. 2023 is calculated as:

	Days Sales Outstanding (Q: Sep. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Jun. 2023 )	+	Accounts Receivable (A: Sep. 2023 ))	/	count )	/	Revenue (A: Sep. 2023 )	*	Days in Period
=	( (5.556	+	4.576)	/	2 )	/	12.468	*	365 / 4
=	5.066					/	12.468	*	365 / 4
=	37.08

NantHealth (OTCPK:NHIQ) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

NantHealth Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of NantHealth's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

NantHealth (NantHealth) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » NantHealth Inc (OTCPK:NHIQ) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

N/A

Address

3000 RDU Center Drive, Suite 200, Morrisville, NC, USA, 27500

Website

https://www.nanthealth.com

NantHealth Inc is a healthcare company that employs precision medicine and technology to give physicians, payers, and patients more information. The company develops software and hardware to collect, indexes, analyze and interpret molecular, financial, clinical, and operational data points to improve decision-making. The company provides cancer care solutions, provide solutions, and payer solutions.

Executives

Rao Haris Naseem	director, 10 percent owner, officer: Chief Executive Officer	C/O NANTHEALTH, INC., 760 W. FIRE TOWER RD., SUITE 107, WINTERVILLE NC 28590
Summus Holdings Llc	10 percent owner	2871 LAKE VISTA DR, SUITE 210, LEWISVILLE TX 75067
Ronald Allen Louks	officer: Chief Operating Officer	C/O NANTHEALTH, INC., 9920 JEFFERSON BLVD., CULVER CITY CA 90232
Nant Capital, Llc	10 percent owner	9922 JEFFERSON BOULEVARD, CULVER CITY CA 90232
Patrick Soon-shiong	director, 10 percent owner, officer: See Remarks	9922 JEFFERSON BOULEVARD, CULVER CITY CA 90232
Deanna L. Wise	director	C/O NANTHEALTH, INC., 9920 JEFFERSON BLVD, CULVER CITY CA 90232
Bob Petrou	officer: Interim CFO	C/O NANTHEALTH, INC., 9920 JEFFERSON BLVD., CULVER CITY CA 90232
Mp 13 Ventures, Llc	10 percent owner	9922 JEFFERSON BOULEVARD, CULVER CITY CA 90232
Cambridge Equities, Lp	10 percent owner	9922 JEFFERSON BOULEVARD, CULVER CITY CA 90232
Allscripts Healthcare Solutions, Inc.	10 percent owner	222 MERCHANDISE MART PLAZA, SUITE 2024, CHICAGO IL 60654
Nantworks, Llc	10 percent owner	9922 JEFFERSON BOULEVARD, CULVER CITY CA 90232
Investment Office Kuwait	10 percent owner	15 CARTER LANE, LONDON X0 EC4V 5EY
Miller Edward D Jr	director	JOHNS HOPKINS, 733 NORTH BROADWAY - SUITE 100, BALTIMORE MD 21205
Kuwait Investment Authority On Behalf Of The Govt Of Kuwait	10 percent owner	C/O HOMEPLACE OF AMERICA INC, 3200 POTTERY DRIVE, MYRTLE BEACH SC 29579
James Mark Burnett	director	640 N. SEPULVEDA BLVD., LOS ANGELES CA 90049